Drugs / Anaerobic Cultivated Human Intestinal Microbiome
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04300426 | Sep 2020 → Jun 2022 | systemic sclerosis | Oslo University Hospital | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anaerobic Cultivated Human Intestinal Microbiome | “single-donor bacterial culture 'Anaerobic Cultivated Human Intestinal Microbiome (ACHIM).'” PMID 34168032 ↗ Jun 2021 |
| Known as | ACHIM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04300426 ↗ |
| Modality | Other / unclassified | “single-donor bacterial culture” PMID 34168032 ↗ Jun 2021 |
| Route | Other | “will be administered by gastroduodenoscope twice” NCT04300426 ↗ |